MAPK6 and lung carcinoma: On the one hand, ERK3 has been shown to promote cancer cell growth and migration in culture conditions and tumor growth and metastasis in xenograft mouse models of different human cancers, including lung cancer [3, 4, 5, 6], head and neck cancer [7], and breast cancer [8, 9, 10].